companies with glp 1 drugs Insurance scrambling to support need for GLP-1 - The C.O.R.E. Group Food companies are targeting users
Description
Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells

I feel like this list is incomplete

Diabetes Relat

The most commonly observed adverse effects in clinical studies are gastrointestinal in nature, consistent with the GLP-1 receptor agonist class
In particular, the SAVOR-TIMI 53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial evidenced neutral effects of saxagliptin in terms of cardiovascular outcomes, but an increased risk of hospitalization for HF, especially in patients with high levels of natriuretic peptides, previous HF, or chronic kidney disease [148]
